| From: |
Gabriel ADEYEMO [ profile ] |
| Subject: |
Anti-HIV gel being evaluated in pregnant and breastfeeding women
|
| Sent: |
Jun 29th, 2011 - 05:07:07 |
|
| |
Source:* Microbicide Trials Network*
http://www.firstscience.com/home/news/biology/anti-hiv-gel-being-evaluated-in-pregnant-and-breastfeeding-women_108007...
Fellow Advocates,
Determining whether a promising HIV prevention gel is safe for women to use
while they are pregnant or breastfeeding is the aim of a new clinical trial
being conducted by the National Institutes of Health-funded Microbicide
Trials Network (MTN). Researchers are hopeful that the study -- the first
clinical trial of the vaginal microbicide tenofovir gel in breastfeeding
women and only the second in pregnant women -- will bring them a step closer
to developing a safe and effective HIV prevention product women can use
throughout their lives. The Phase I trial is underway at two U.S. sites --
Magee-Womens Hospital of the University of Pittsburgh Medical Center and the
University of Alabama, Birmingham (UAB) -- but has implications for women
throughout the globe...
"Tenofovir gel and other vaginal microbicides under development are intended
to be used by sexually active women -- the very women most likely to get
pregnant -- yet we have very little information about whether these products
are safe for them to use," said Richard Beigi, M.D., M.Sc., assistant
professor of obstetrics, gynecology and reproductive sciences at the
University of Pittsburgh School of Medicine, who is leading the study. "In
fact, HIV prevention may be most critical during pregnancy due to heightened
immune responses or hormonal changes that appear to make pregnant women
twice as likely to be infected by sexual partners. Most women also continue
to be sexually active and use medication while they are pregnant and
breastfeeding, so we need to know if products like tenofovir gel are safe
for women and their babies before they become widely available," he added...
Depending on results of the study, which are expected in late 2012, the
researchers will likely embark on a larger international trial involving a
greater number of pregnant women, including those at earlier gestational
ages.
This is an interesting piece for all of us in the field of prevention
technologies and you can read more information by clicking the link above.
--
Many Thanks
Yours' in Prevention Science
Gabriel, ADEYEMO
Regional Focal Point - West Africa
Global Youth Coalition on HIV/AID (GYCA)
+234-80-6798-7317 | gabriel (at) gyca.org
www.gyca.org | www.tigweb.org
GYCA is a youth-led global network of more than 5,500 young leaders and
adult allies working on youth and HIV/AIDS in over 173 countries world-wide.
GYCA's mission is to empower young leaders with the skills, knowledge,
resources and opportunities they need to scale up HIV/AIDS interventions
amongst their peers.
Universal Access is possible; *
*Zero new HIV infections. **Zero discrimination and ***Zero AIDS-related
deaths.***
|
|
Message
back to messages
